Equity
€1.3m ▲ 8.4%
DENEUCARE has made a profit in every financial year since 2006.
DENEUCARE
Lifetime
19 annual accounts with figures on one time axis, 22 filings since 2003peak €186,593 (2024)
€186,593▲ 14.8%
peak €116,394 (2009)
€98,460▲ 13.6%
peak €1.3m (2024)
€1.3m▲ 8.4%
€846,181▲ 2.3%
Board1 name since 2002
1 director
Documentsfilings and deeds
31-08-202531 days late
2024micro format
Gross margin from €162,534 to €186,593
Key points
from the 2024 annual accountsFilings
22 annual accounts 106 days past the deadline
2025 accounts not filed: deadline was 31-07-2026.
Position in the sector
€1.3m
More equity than 95% of companies in human health. Sector median €147,644 · 19,782 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 14,768 companies had the same profile as DENEUCARE has now. Each dot stands for 37 companies, two years later.
96.1%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 14,768 companies, not a prediction for DENEUCARE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0478940270
Change of role: , from manager to director
Gazette deed
Incorporation
published on 12-12-2002 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DENEUCARE Ottignies-Louvain-la-Neuve | €2.1m | €186,593 | 59.9% | - |
| SOCIETE MEDICALE DU DOCTEUR CUVELIER PIERRE Gerpinnes | €2.2m | €198,360 | 83.3% | - |
| Dr. THYWISSEN Diepenbeek | €2.2m | €190,523 | 97.7% | - |
| KARAR MEDICAL Brussels | €2.2m | €206,785 | 4.9% | - |
| DR. GEERT PAGE Poperinge | €1.9m | €173,292 | 34.9% | - |
| DR. KOEN MELIS Knokke-Heist | €1.8m | €187,851 | 83.4% | - |
| HERRANDOU Waterloo | €2.0m | €177,795 | 75.6% | - |
These companies have the same main activity as DENEUCARE: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.8m and €2.2m, founded between 2000 and 2009.
Official details
Source: KBO- Status
- Active since 05-12-2002Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Financial year end
- 31 December
- Peppol
- Reachable since 08-12-2025
Insights on DENEUCARE
DENEUCARE files the micro format. That format states no turnover. The gross margin rose from €57,843 in 2006 to €186,593 in 2024.
The balance sheet grew most from 2018 to 2020 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about DENEUCARE
- What is the company number of DENEUCARE?
- The company number of DENEUCARE is 0478.940.270. The VAT number is the same number with BE in front: BE 0478.940.270.
- Where is DENEUCARE based?
- The registered office is at Rue de Pallandt 7, 1341 Ottignies-Louvain-la-Neuve.Company details
- What does DENEUCARE do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of DENEUCARE?
- DENEUCARE is a private limited company (BV).
- When was DENEUCARE founded?
- DENEUCARE was founded on 05-12-2002.
- Is DENEUCARE still active?
- Yes, DENEUCARE is an active enterprise in the KBO register.
- What is the turnover of DENEUCARE?
- The turnover in financial year 2024 is ≈ €350,000. This figure is estimated from the gross margin of €186,593 and 40 comparable companies (NACE 86220). It probably lies between €290,000 and €460,000.Financials
- Is DENEUCARE profitable?
- In financial year 2024, DENEUCARE made a profit of €98,460.
- Where can I find the annual accounts of DENEUCARE?
- DENEUCARE filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.